ONCOCIT explica cómo la Inmunoterapia Personalizada Cambia el Paradigma del Tratamiento del Cáncer

1. ONCOCIT explica cómo la Inmunoterapia Personalizada Cambia el Paradigma del Tratamiento del Cáncer Oncology is at an inflection point. Over the past two decades, advances in personalized immunotherapy have shown promising results in the battle against cancer. By targeting the patient's immune system, these revolutionary treatments offer a more effective and less invasive strategy compared to traditional methods such as chemotherapy. With the collaboration of the specialized clinic ONCOCIT Chile, we are advancing on this issue. The Role of the Immune System in the Fight Against Cancer The immune system acts as the body's first and last line of defense against cancer. However, when a person has cancer, this system is compromised. Cancer cells find ways to “dodge” the immune system, – explains Dr. Ider Rivadeneira , LATAM Director of the ONCOCIT USA Cancer Education Center, for the ONCOVIX program – resulting in uncontrolled growth and spread of the disease. Immunotherapy, therefore, aims to "reprogram" the immune system so that it can identify and destroy cancer cells more effectively.

2. Beyond Traditional Immunotherapy Although the term "immunotherapy" defines a general category of treatment, there are several levels and types of immunotherapy to consider. The most advanced approaches involve personalizing treatment according to the type of cancer and the patient's genomic profile – detail the Immunotherapy specialists at ONCOCIT . Complex algorithms are developed to integrate genetically targeted immunotherapy options, significantly increasing treatment efficacy. The problem of Resistance to Chemotherapy Almost 90% of cancer deaths are due to metastasis and resistance to chemotherapy . Traditional chemotherapy treatments, although effective in certain cases, can be insufficient and sometimes harmful to the immune system. The combination of immunotherapy with chemotherapy or other treatments – they explain in ONCOCIT – is showing an increase in success rates in cancer treatment. One of the most notable aspects of immunotherapy advances is its applicability in cases of stage 4 cancer, where treatment options are often limited and the prognosis is generally poor. Immunotherapy at this advanced stage is showing signs of success in stopping or even reversing disease progression in some cases. This late-stage treatment approach is transforming the outlook for patients who previously had few options. This impact on advanced cases reaffirms the importance of personalized treatment approaches and emphasizes the need for centers of excellence in oncology that can offer these innovative therapies. Incorporating this new immunotherapy approach against stage 4 cancer further expands the horizon of immunotherapy therapies, reaffirming its revolutionary role in the future of oncology. ONCOCIT explains Innovations in Immunotherapy New forms of immunotherapy include "cancer vaccines" designed to train the immune system to identify cancer cells. Additionally, "adoptive cell immunotherapy" involves genetically modifying the patient's immune cells in the laboratory to improve their effectiveness in fighting cancer. One of the most exciting developments in the field of immunotherapy is “cancer vaccines . ” Unlike traditional vaccines that prevent infectious diseases, these are designed to activate the immune system against cancer already present in the body.

3. These vaccines work by teaching the immune system to recognize specific antigens present on cancer cells, allowing the body to attack and destroy the tumor more effectively. This approach – details immunotherapy specialist Ider Rivadeneira – has the potential to be a game- changer, especially for cancers that have proven resistant to other treatment methods. “Adoptive cell immunotherapy” is another revolutionary strategy that is gaining traction in the medical community. In this approach, – continues Rivadeneira – immune cells are taken from the patient and genetically modified in a laboratory to improve their ability to fight cancer. Once these cells have been "trained," they are reintroduced into the patient's body, where they can identify and destroy cancer cells with surgical precision. Personalized immunotherapy is emerging as a key player in the future of cancer treatment. By offering a more precise and less invasive way to combat the disease, this innovation represents real hope for cancer patients at various stages and types. However, it is crucial that patients seek centers of excellence in oncology, such as ONCOCIT, that can offer these advanced treatments to ensure success in their fight against this devastating disease.